Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Carcinoma, Basal Cell 7Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 3Keratosis, Actinic 3Cholangiocarcinoma 3Tongue Neoplasms 2Pleural Diseases 2Non-Muscle Invasive Bladder Neoplasms 2Mycosis Fungoides 2Mesothelioma, Malignant 2Carcinoma, Transitional Cell 2Bile Duct Neoplasms 2Basal Cell Nevus Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Skin Neoplasms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Photosensitivity Disorders 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain 1Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1

Interventions

Iodine-131 21lenvatinib 17Magnetic Resonance Spectroscopy 17trametinib 13Sorafenib 13Thyrotropin Alfa 12pembrolizumab 11dabrafenib 11Thyroidectomy 10Surgical Procedures, Operative 10Thyroxine 9Paclitaxel 9vandetanib 8selpercatinib 8Sunitinib 7Nivolumab 7Fluorodeoxyglucose F18 7cabozantinib 6anlotinib 6Everolimus 6Biopsy 6pazopanib 5Vemurafenib 5Triiodothyronine 5Specimen Handling 5Saline Solution 5Radiotherapy 5Radiofrequency Ablation 5Iodine-124 5Cyclophosphamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡